Bismuth compounds have been widely used in medicine for more than 200
years, and new bismuth-containing drugs are now being developed. Howev
er the biological chemistry of bismuth is poorly understood. We review
here methods for the study of bismuth compounds, and use of Bi(III) i
n antiulcer, antibacterial, anti-HIV and radiotherapeutic agents is de
scribed. The chemistry of Bi(III) carboxylates and amino-carboxylates
is dominated by intermolecular interactions which lead to polymeric st
ructures. Bi(III) exhibits a highly variable coordination number and c
oordination geometry, and alkoxide ligands can induce a strong stereoc
hemical ''lone-pair effect''. Bi(III) can bind to both Zn(II) sites (e
.g. metallothionein) and Fe(III) sites (e. transferrin) in proteins. F
urther work is needed to understand the relationship between the struc
tures and dynamics of bismuth compounds and their bioactivity.